Writer, the enterprise AI agent platform used by Fortune 500 companies including Accenture, Uber, and Vanguard, released its new flagship model Palmyra X6 today, alongside a rebuilt agent ...

Minecraft master Craftee harnesses the power of rapidly duplicating magical upgrades to withstand the many dangers of his blocky environment. Karoline Leavitt leaving White House press secretary role ...

Wednesday, Aug. 5, 2026 at 8:00 a.m. ET Revenue -- $277.8 million, growing 26.6% year over year reflecting strong execution of the Home to Gate strategy and network expansion. Total Bookings -- $295.9 ...

States are pushing to pass laws sanctioning more reasons to use lethal violence in self-defense, a distinctly American ...

Q3 2026 Revenue Guidance -- $945 million to $975 million, which represents a 4.5% sequential increase at the midpoint. Q3 2026 Gross Margin Guidance -- 24.0%, plus or minus 50 basis points, reaching ...

On Tuesday, Treasury Secretary Scott Bessent said the U.S. would examine open source models from China for signs of intellectual property theft, threatening sanctions against Chinese AI companies if ...

As access to Anthropic’s and OpenAI’s frontier models becomes more restricted, Chinese labs are pitching their open-source alternatives as stable, accessible, and increasingly capable. Silicon Valley ...

The SEC proposal would substantially expand access to registered offerings by opening Form S-3 shelf registration to significantly more ...

Kimi and other free models from China have again been seen as a wake-up call. But for what? This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in ...

StarSpark AI tutor Sparky uses speech, handwriting recognition and grade-level pacing to teach students math reasoning rather than just delivering answers.

Silicon Valley and Washington are debating a multibillion-dollar question: Should American companies be able to use Chinese artificial-intelligence models? OpenAI and Anthropic executives are sounding ...

In cell culture labs around the world, human brain organoids live out their short lives as neural guinea pigs, testing the effects of diseases, toxins, and new pharmaceuticals. But they may soon be on ...